GaldermaReportsStrongStarttotheYear,DeliveringFirstQuarter2026NetSalesof1.473BillionUSD,Growing25.5%atConstantCurrency
===2026/4/23 16:09:31===
17.1%
Fillers & Biostimulators
236
284
14.0%
20.1%
Dermatological Skincare
370
441
17.0%
19.3%
Therapeutic Dermatology
212
385
71.3%
81.4%
of which Nemluvio
=*=*=*=*=*=
当前为第18/27页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页